We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Doctors Without Borders Seeks To Undo Gilead Hep C Patent

Law360 (December 5, 2018, 7:51 PM EST) -- Doctors Without Borders and five organizations have appealed the European Patent Office’s decision upholding Gilead Sciences Inc.’s patent for the hepatitis C drug sofosbuvir, the international nonprofit announced on Wednesday....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.